H-Thr(Bzl)-OH·HCl CAS:60856-51-1

Mukugadzirwa kwepeptide, H-Thr(Bzl)-OH·HCl inoita basa rakakosha se amino acid derivative yakachengetedzwa inobviswa dziviriro uye kushanda kuti ibatanidzwe nemamwe ma amino acids kuti igadzire ma peptide chains. Maitiro aya anoda kutarisisa kwakanyatsonaka mamiriro ekuita uye matekiniki ekuchenesa kuchengetedza kusimba kwekomputa uye kugadzira zvigadzirwa zve peptide zvemhando yepamusoro. Vatsvaguriri nesainzi yemishonga vanobatanidza nokungwarira H-Thr(Bzl)-OH·HCl muma protocol avo ekugadzira kuti vagadzire ma peptide sequences chaiwo anoratidza basa re biological kana therapeutic potential. Kuchena uye kugadzikana kwekomputa kwakasimba kwakakosha pakuona mhedzisiro inodzokororwa mukugadzirwa kwepeptide, zvichibatsira mukuvandudzwa kwemishonga mitsva uye bioactive compounds. Uyezve, kuwirirana kweH-Thr(Bzl)-OH·HCl nenzira dze solid-phase synthesis kunoita kuti ishandiswe zvakanaka mu automated peptide synthesizers, zvichiita kuti kugadzirwa kwe peptides dzakasarudzika uye maraibhurari e peptide kuwedzeredzwe kuti mishonga iwanikwe uye kushandiswa kwekutsvaga. Basa rayo mukugadzira ma peptide akasiyana-siyana rinoita kuti ive chishandiso chakakosha chekugadzirisa matambudziko akasiyana-siyana e biomedical uye kutsvaga nzira itsva dzekurapa. Zvose, kukosha kweH-Thr(Bzl)-OH·HCl mukuumbwa kwepeptide kunosvika pakutsvagurudza kwemishonga, biotechnology, uye chemistry yekurapa, uko kunoramba kuchibatsira kugadzirwa kwemishonga mitsva yakavakirwa papeptide uye biopharmaceuticals, zvichitungamira kufambira mberi muhutano nesainzi yehupenyu.